[ Price : $8.95]
FDA schedules an 11/6 Digital Health Advisory Committee meeting to examine the rise of generative artificial intelligence in digit...[ Price : $8.95]
Capsida Biotherapeutics stops enrollment in its SYNRGY clinical trial that is evaluating gene therapy CAP-002 for treating STXBP1 ...[ Price : $8.95]
FDA commissioner Marty Makary reinstates CBER director Vinay Prasads previous additional duties as the agencys chief medical and s...[ Price : $8.95]
FDA publishes a draft guidance to assist in developing non-opioid analgesics to treat chronic pain.[ Price : $8.95]
FDA clears a new indication for neurocare groups Apollo TMS therapy device to treat adolescents with major depressive disorder.[ Price : $8.95]
FDA approves a Johnson & Johnson NDA for Inlexzo (gemcitabine intravesical system) for adults with non-muscle invasive bladder can...[ Price : $8.95]
FDA grants Greenwich LifeSciences fast track status for GLSI-100 for preventing breast cancer recurrences.[ Price : $8.95]
In a new crackdown on drug advertising, FDA orders pharmaceutical companies to remove any noncompliant ads and bring all promotion...